Mark H. Einstein, MD, MS
Professor and Vice Chair for Research of Obstetrics & Gynecology and Women's Health
Albert Einstein College of Medicine/Montefiore Medical Center
1695 Eastchester Rd., Suite 601
Bronx,
NY
USA
10461
Biographical Sketch: I have been very active and funded in translational clinical trials for cervical cancer prevention Also, I have been one of the leaders for 1) ASCCP Cervical Screening and Management Guidelines, 2) American Cancer Society and SGO separate recommendations for HPV vaccines, 3) World Health Organization. I have been a presenter or discussant at SGO many times. I have also been a prior SGO program committee member."
Papers:
100 - Featured Poster
Phase II trial of pemetrexed and carboplatin in platinum-sensitive recurrent ovarian, Fallopian tube, and primary peritoneal cancer
192 - Poster Session A
Exome sequencing identifies germline mutations involving novel single nucleotide polymorphisms within DNA repair pathway genes in uterine serous carcinoma
274 - Poster Session A
The PI3K inhibitor GDC-0941 is synergistic with lapatinib and mediates endocrine sensitivity in uterine papillary serous carcinoma via AKT
444 - Poster Session B
Prospective Phase II Trial of Adjuvant Pelvic Radiation “Sandwiched” Between Combination Paclitaxel/Carboplatin Chemotherapy in Women with Uterine Papillary Serous Carcinoma (UPSC)
524 - Poster Session B
Prevalence of cognitive impairment, pain, depression, and neuropathy in women with gynecologic malignancies